Use of cytomegalovirus immune globulin and ganciclovir for the prevention of cytomegalovirus disease in lung transplantation

1 December 2001

journal article
review article
Published by Wiley in Transplant Infectious Disease

Vol. 3 (s2) , 49-56
https://doi.org/10.1034/j.1399-3062.2001.00010.x

Abstract

Cytomegalovirus (CMV) infection and disease continue to be significant causes of morbidity and mortality in lung transplant recipients. The potential benefits of CMV prophylaxis extend beyond prevention of the immediate CMV infection to potentially preventing CMV‐associated complications, including superinfection due to Aspergillus bacteria, and other opportunistic infections, and bronchiolitis obliterans syndrome (BOS). Longer courses of prophylactic intravenous (IV) ganciclovir, sequential IV/oral therapy, addition of intravenous CMV immune globulin (CMV‐IGIV), surveillance tests, and investigation of the role of hypogammaglobulinemia are a few of the strategies and issues being evaluated to improve CMV prophylaxis and, consequently, graft and patient survival.

Keywords

This publication has 20 references indexed in Scilit:

INCREASED HUMAN CYTOMEGALOVIRUS (HCMV) DNA LOAD IN PERIPHERAL BLOOD LEUKOCYTES AFTER LUNG TRANSPLANTATION CORRELATES WITH HCMV PNEUMONITIS1
Transplantation, 2001
PREEMPTIVE THERAPY OF CYTOMEGALOVIRUS DNAEMIA DECREASES CYTOMEGALOVIRUS-ASSOCIATED ACUTE REJECTION AND POSSIBLY CHRONIC REJECTION FOLLOWING LUNG TRANSPLANTATION.
Transplantation, 2000
Cytomegalovirus immune globulin (CMVIG) in combination with gancyclovir provides cost-effective prophylaxis of CMV after lung transplantation (LTX): MR Zamora, D Sherman, JJ Olmos, F Torres and TN Hodges. Univ. of Colorado Health Sciences Ctr, Denver, CO
The Journal of Heart and Lung Transplantation, 1999
PREEMPTIVE TREATMENT FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE
Transplantation, 1998
EFFICACY OF A 6-WEEK PROPHYLACTIC GANCICLOVIR REGIMEN AND THE ROLE OF SERIAL CYTOMEGALOVIRUS ANTIBODY TESTING IN LUNG TRANSPLANT RECIPIENTS
Transplantation, 1995
Detection of human cytomegalovirus antigenaemia: a rapid diagnostic technique for predicting cytomegalovirus infection/pneumonitis in lung and heart transplant recipients.
Thorax, 1995
A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.
American Journal of Respiratory and Critical Care Medicine, 1994
THE COST IMPACT OF CYTOMEGALOVIRUS DISEASE IN RENAL TRANSPLANT RECIPIENTS
Transplantation, 1993
Sequelae of Cytomegalovirus Pulmonary Infections in Lung Allograft Recipients
American Review of Respiratory Disease, 1992
IMMUNOGLOBULIN ABNORMALITIES IN RENAL TRANSPLANT RECIPIENTS
Transplantation, 1989